4-Methyl-N-(3-pyridin-2-yl-isoquinolin-1-yl)-benzamide

ID: ALA339261

Cas Number: 112575-49-2

PubChem CID: 10359831

Max Phase: Preclinical

Molecular Formula: C22H17N3O

Molecular Weight: 339.40

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ccc(C(=O)Nc2nc(-c3ccccn3)cc3ccccc23)cc1

Standard InChI:  InChI=1S/C22H17N3O/c1-15-9-11-16(12-10-15)22(26)25-21-18-7-3-2-6-17(18)14-20(24-21)19-8-4-5-13-23-19/h2-14H,1H3,(H,24,25,26)

Standard InChI Key:  XKGYBIWGVCSKAC-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
   -1.3875   -0.1542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8708    0.1458    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3875   -0.7542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9125   -1.0542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8708    0.7458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9083    0.1458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3958    1.0458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9083    0.7458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9125   -1.6542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3500    1.0458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1667    0.7583    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4333   -0.7542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4375   -1.9417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4000   -1.9542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4000   -2.5542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4458   -2.5417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9250   -2.8542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4250    1.0458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4250   -0.1667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6875    1.0583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3625    1.6458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9333   -3.4542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9500    0.7333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6750    1.6583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9500    0.1333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1500    1.9583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  1  1  0
  4  3  1  0
  5  2  1  0
  6  1  1  0
  7  8  1  0
  8  6  1  0
  9  4  1  0
 10  5  1  0
 11 10  2  0
 12  4  2  0
 13  9  2  0
 14  9  1  0
 15 14  2  0
 16 13  1  0
 17 15  1  0
 18  8  2  0
 19  6  2  0
 20 11  1  0
 21 10  1  0
 22 17  1  0
 23 25  2  0
 24 26  1  0
 25 19  1  0
 26 21  2  0
  5  7  2  0
 18 23  1  0
 16 17  2  0
 20 24  2  0
M  END

Alternative Forms

Associated Targets(Human)

ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mycoplasmoides gallisepticum (165 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adora1 Adenosine A1 receptor (6163 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adora2a Adenosine A2a receptor (3360 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 339.40Molecular Weight (Monoisotopic): 339.1372AlogP: 4.86#Rotatable Bonds: 3
Polar Surface Area: 54.88Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.96CX LogP: 5.15CX LogD: 5.15
Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.58Np Likeness Score: -1.11

References

1. van Muijlwijk-Koezen JE, Timmerman H, Link R, van der Goot H, Ijzerman AP..  (1998)  A novel class of adenosine A3 receptor ligands. 2. Structure affinity profile of a series of isoquinoline and quinazoline compounds.,  41  (21): [PMID:9767637] [10.1021/jm980037i]
2. de Zwart MA, van der Goot H, Timmerman H..  (1988)  Synthesis and copper-dependent antimycoplasmal activity of 1-amino-3-(2-pyridyl)isoquinoline derivatives. 1. Amides.,  31  (4): [PMID:3351847] [10.1021/jm00399a005]
3. Tafi A, Bernardini C, Botta M, Corelli F, Andreini M, Martinelli A, Ortore G, Baraldi PG, Fruttarolo F, Borea PA, Tuccinardi T..  (2006)  Pharmacophore based receptor modeling: the case of adenosine A3 receptor antagonists. An approach to the optimization of protein models.,  49  (14): [PMID:16821770] [10.1021/jm051112+]

Source